Elevation OncologyELEV
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 65 institutions reported holding Elevation Oncology Inc. (ELEV) in their 13F filings, down 7 from Q1 2025. 24 opened new positions and 32 sold out. The largest holders were Frazier Life Sciences Management, L.P. ($2.2M), BML Capital Management, LLC ($2.2M) and Aisling Capital Management LP ($1.0M). 4 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Elevation Oncology Inc.
- CUSIP
- 28623U101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 24 | $2.9M |
| Exits | 32 | $1.9M |
All 13F filers, Q1 2025 → Q2 2025: 9,400,855 shares bought and 13,708,428 shares sold, net −4,307,573 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 65 holders
| Frazier Life Sciences Management, L.P. | 0.09% | No change | 5,993,579 | $2.2M |
| BML Capital Management, LLC | 1.66% | Reduce -0.0% | 5,890,434 | $2.2M |
| Aisling Capital Management LP | 0.29% | No change | 2,834,910 | $1.0M |
| Vanguard Group Inc. | 0.00% | Reduce -12.7% | 2,256,690 | $828K |
| Opaleye Management Inc. | 0.11% | New | 1,442,061 | $529K |
| Deltec Asset Management LLC | 0.09% | New | 1,436,363 | $527K |
| Millennium Management | 0.00% | New | 1,424,446 | $523K |
| Susquehanna International Group, LLP | 0.00% | Add +1376.3% | 1,010,308 | $371K |
| Rangeley Capital, LLC | 0.43% | New | 905,289 | $332K |
| ExodusPoint Capital Management, LP | 0.00% | New | 597,017 | $219K |
| Geode Capital Management, LLC | 0.00% | Reduce -54.6% | 538,656 | $198K |
| BlackRock, Inc. | 0.00% | Reduce -88.4% | 369,048 | $135K |
| Diadema Partners LP | 0.08% | New | 362,935 | $133K |
| Citadel Advisors | 0.00% | New | 355,203 | $130K |
| Sphera Funds Management LTD. | 0.03% | Reduce -8.4% | 328,562 | $121K |
| GTS Securities LLC | 0.00% | New | 300,029 | $110K |
| Palumbo Wealth Management LLC | 0.03% | Add +6.2% | 295,328 | $108K |
| Ameriprise Financial Inc. | 0.00% | Reduce -1.5% | 294,326 | $108K |
| Yakira Capital Management, Inc. | 0.04% | New | 263,097 | $97K |
| Jane Street Group, LLC | 0.00% | Add +465.3% | 255,443 | $94K |
| Two Sigma Investments, LP | 0.00% | Add +31.1% | 254,295 | $93K |
| Goldman Sachs Group Inc. | 0.00% | Add +192.5% | 224,159 | $82K |
| UBS Group AG | 0.00% | Add +73.2% | 201,655 | $74K |
| PenderFund Capital Management Ltd. | 0.04% | New | 195,700 | $72K |
| State Street Corp. | 0.00% | Reduce -81.6% | 194,800 | $72K |
| Renaissance Technologies | 0.00% | Reduce -74.4% | 165,829 | $61K |
| Marshall Wace, LLP | 0.00% | New | 154,793 | $57K |
| Exome Asset Management LLC | 0.03% | New | 110,353 | $41K |
| Two Sigma Advisers, LP | 0.00% | Reduce -44.4% | 107,400 | $39K |
| Northern Trust Corp. | 0.00% | Reduce -80.2% | 90,912 | $33K |
| Persistent Asset Partners Ltd | 0.03% | New | 83,416 | $31K |
| Verition Fund Management LLC | 0.00% | Reduce -82.5% | 76,503 | $28K |
| Qube Research & Technologies Ltd | 0.00% | New | 67,377 | $25K |
| AQR Capital Management | 0.00% | Reduce -10.2% | 51,672 | $19K |
| Virtu Financial LLC | 0.00% | New | 50,318 | $18K |
| FMR LLC | 0.00% | Add +307.8% | 48,868 | $18K |
| National Bank of Canada | 0.00% | Add +33.3% | 40,000 | $15K |
| HRT Financial LP | 0.00% | New | 38,243 | $14K |
| Abel Hall, LLC | 0.01% | New | 32,799 | $12K |
| CSS LLC | 0.00% | New | 30,000 | $11K |
| Nuveen, LLC | 0.00% | Reduce -86.3% | 23,913 | $9K |
| Simplex Trading, LLC | 0.00% | Add +15.8% | 22,784 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -8.2% | 17,724 | $7K |
| Morgan Stanley | 0.00% | Reduce -81.4% | 16,608 | $6K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | New | 14,016 | $5K |
| Citigroup Inc. | 0.00% | Reduce -83.2% | 13,442 | $5K |
| Two Sigma Securities, LLC | 0.00% | Reduce -32.6% | 12,717 | $5K |
| Balyasny Asset Management L.P. | 0.00% | New | 12,320 | $5K |
| FNY Investment Advisers, LLC | 0.00% | New | 10,000 | $3K |
| Cwm, LLC | 0.00% | Reduce -5.0% | 5,030 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -92.1% | 5,207 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -22.9% | 5,082 | $2K |
| Royal Bank of Canada | 0.00% | Add +38.2% | 1,793 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | New | 1,961 | $720 |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $720 |
| Bank of America Corp. | 0.00% | Reduce -96.1% | 1,479 | $543 |
| Archer Investment Corp | 0.00% | No change | 1,298 | $476 |
| Wells Fargo & Company | 0.00% | Reduce -98.5% | 444 | $163 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -44.3% | 220 | $81 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 133 | $49 |
| Group One Trading LLC | 0.00% | Add +18.0% | 118 | $43 |
| EverSource Wealth Advisors, LLC | 0.00% | Add +194.7% | 56 | $21 |
| Essential Partners LLC | 0.00% | — | 24 | $9 |
| True Wealth Design, LLC | 0.00% | Reduce -90.0% | 3 | $2 |
| Raymond James Financial Inc. | 0.00% | New | 2 | $1 |
"% of holder's portfolio" is ELEV's weight in each manager's 13F, not the share of Elevation Oncology Inc. the manager owns.